Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital dream team: personalized advice may cut Long-Term sick leave

NCT ID NCT05575908

Disease control Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether a digital expert team can help people on long-term sick leave with muscle or common mental health issues return to work. Participants fill out a digital questionnaire and have a video meeting with their doctor and a team of specialists who then create a personalized plan. The trial compares this approach to usual care and measures how quickly people return to work within 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a digital expert team providing personalized advice and a coordinated care pathway
What this could lead to
If effective, this approach could offer a scalable way to help people on long-term sick leave return to work sooner by coordinating healthcare and welfare services.
What could go wrong
This is a relatively small trial in one region of Norway, so results may not apply elsewhere. The intervention depends on digital tools and team availability, which may limit its use in other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 170 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2022

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Sick-listed minimum 50% between 11 and 20 weeks * Musculoskeletal disorder and/or common mental disorder * Living in the county of Trøndelag or Møre- og Romsdal Exclusion Criteria: * Specific conditions such as fracture, trauma, infections, malignancy, dislocations, etc. * Serious mental conditions or another serious disease that makes participation difficult * Most likely to return to work within 2 weeks * Not speaking/reading Norwegian

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mental disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mental disorder musculoskeletal system disorder psychiatric disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mental disorder Musculoskeletal diseases

Contacts and locations

Locations

  • Molde Sjukehus

    Molde, Midt-Norge, 6412, Norway

  • St. Olavs hospital HF

    Trondheim, Midt-Norge, 7006, Norway

  • Sykehuset Levanger

    Levanger, Midt-Norge, 7600, Norway

  • Ålesund sjukehus

    Ålesund, Midt-Norge, 6017, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.